• LAST PRICE
    10.4600
  • TODAY'S CHANGE (%)
    Trending Down-0.1700 (-1.5992%)
  • Bid / Lots
    10.4600/ 7
  • Ask / Lots
    10.4700/ 6
  • Open / Previous Close
    10.6600 / 10.6300
  • Day Range
    Low 10.3710
    High 11.0877
  • 52 Week Range
    Low 1.7600
    High 17.5666
  • Volume
    1,728,190
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 10.63
TimeVolumeARQT
09:32 ET5001810.79
09:33 ET680510.71
09:35 ET1974110.752
09:37 ET1673910.7097
09:39 ET4534110.935
09:42 ET3026911.06
09:44 ET2952810.8727
09:46 ET3098110.66
09:48 ET2821310.55
09:50 ET3587110.6634
09:51 ET926410.7
09:53 ET2355510.8
09:55 ET1085410.81
09:57 ET1246210.84
10:00 ET1514810.95
10:02 ET3282710.89
10:04 ET988910.7767
10:06 ET605410.63
10:08 ET681910.68
10:09 ET1495010.59
10:11 ET3247410.6
10:13 ET1731810.5986
10:15 ET2464010.4997
10:18 ET2265210.5489
10:20 ET4684410.65
10:22 ET2471410.715
10:24 ET1368410.835
10:26 ET2897610.73
10:27 ET866410.71
10:29 ET427610.7122
10:31 ET664610.78
10:33 ET721910.77
10:36 ET1628710.715
10:38 ET1008410.655
10:40 ET992110.67
10:42 ET1821510.72
10:44 ET543610.755
10:45 ET506910.7
10:47 ET876810.75
10:49 ET210010.8
10:51 ET306510.88
10:54 ET891010.9
10:56 ET461710.8198
10:58 ET100010.81
11:00 ET304210.82
11:02 ET462610.86
11:03 ET634210.78
11:05 ET503310.77
11:07 ET1255510.69
11:09 ET750010.71
11:12 ET864910.72
11:14 ET416010.71
11:16 ET60010.72
11:18 ET130010.72
11:20 ET955210.64
11:21 ET298810.67
11:23 ET530010.62
11:25 ET757710.56
11:27 ET1387810.54
11:30 ET402010.55
11:32 ET805110.5369
11:34 ET4909110.3751
11:36 ET1937410.41
11:38 ET1607210.4
11:39 ET787810.4199
11:41 ET500910.4399
11:43 ET1074510.45
11:45 ET937110.48
11:48 ET1866110.47
11:50 ET1621210.46
11:52 ET1451610.49
11:54 ET686210.51
11:56 ET2670310.48
11:57 ET1230210.4801
11:59 ET455410.52
12:01 ET636810.58
12:03 ET614110.59
12:06 ET528210.54
12:08 ET724610.49
12:10 ET433110.5301
12:12 ET224010.5302
12:14 ET1317710.54
12:15 ET458910.53
12:17 ET584410.445
12:19 ET1615610.46
12:21 ET706610.465
12:24 ET955310.45
12:26 ET1305010.47
12:28 ET860010.49
12:30 ET615710.505
12:32 ET145310.44
12:33 ET720510.48
12:35 ET883610.525
12:37 ET201010.48
12:39 ET911510.455
12:42 ET665210.46
12:44 ET790010.51
12:46 ET351610.4782
12:48 ET339810.49
12:50 ET485910.5
12:51 ET605610.485
12:53 ET193710.48
12:55 ET170010.485
12:57 ET437810.4967
01:00 ET819810.44
01:02 ET1437110.395
01:04 ET870110.49
01:06 ET1400610.48
01:08 ET991810.43
01:09 ET4133710.405
01:11 ET1051010.43
01:13 ET323510.44
01:15 ET270010.43
01:18 ET601910.47
01:20 ET1219710.44
01:22 ET351710.47
01:24 ET673110.45
01:26 ET671310.47
01:27 ET332910.46
01:29 ET740110.465
01:31 ET1186810.48
01:33 ET458810.45
01:36 ET530410.445
01:38 ET353610.46
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesARQT
Arcutis Biotherapeutics Inc
1.0B
-2.4x
---
United StatesVRDN
Viridian Therapeutics Inc
997.0M
-4.0x
---
United StatesCRGX
CARGO Therapeutics Inc
997.2M
0.0x
---
United StatesTYRA
Tyra Biosciences Inc
1.0B
-14.3x
---
United StatesSAVA
Cassava Sciences Inc
971.4M
-10.0x
---
United StatesCABA
Cabaletta Bio Inc
1.0B
-13.8x
---
As of 2024-02-28

Company Information

Arcutis Biotherapeutics, Inc. is a medical dermatology company. The Company is focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its portfolio is comprised of topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. Its lead product, ZORYVE, is for the treatment of plaque psoriasis, including psoriasis in the intertriginous areas, in individuals 12 years of age or older. ZORYVE is a once-daily topical formulation of roflumilast, a highly potent and selective phosphodiesterase-4 (PDE4) inhibitor. PDE4 is an established biological target in dermatology. It is also developing roflumilast cream for the treatment of atopic dermatitis. ZORYVE is designed for simple once-a-day application for chronic use, does not burn or sting on application, and can be used on any part of the body, including sensitive or difficult-to-treat areas, such as the face and intertriginous regions.

Contact Information

Headquarters
3027 Townsgate Road, Suite 300WESTLAKE VILLAGE, CA, United States 91361
Phone
805-418-5006
Fax
302-531-3150

Executives

Independent Chairman of the Board
Patrick Heron
President, Chief Executive Officer, Director
Todd Watanabe
Co-Founder, Senior Vice President, Chief Technology Officer
David Osborne
Interim Chief Financial Officer
John Smither
Senior Vice President, General Counsel
Masaru Matsuda

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.0B
Revenue (TTM)
$49.0M
Shares Outstanding
94.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.15
EPS
$-4.37
Book Value
$3.43
P/E Ratio
-2.4x
Price/Sales (TTM)
20.5
Price/Cash Flow (TTM)
---
Operating Margin
-506.43%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.